The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Chawla Lakhmir S since year 2005.
The trader's CIK number is 1646626.
At the time of this reporting, Chawla Lakhmir S is the Chief Medical Officer of La Jolla Pharmaceutical Co .
(stock ticker symbol LJPC).
See this page for all insider trading activities at La Jolla Pharmaceutical Co .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-01-30||LJPC||La Jolla Pharmaceutical Co||Buy||1,000||5.57||5,570|
|2019-01-29||LJPC||La Jolla Pharmaceutical Co||Buy||2,000||5.56||11,120|
|2017-03-03||LJPC||La Jolla Pharmaceutical Co||Buy||1,000||34.48||34,480|
|2017-03-02||LJPC||La Jolla Pharmaceutical Co||Buy||600||35.33||21,198|
|2015-09-28||LJPC||La Jolla Pharmaceutical Co||Buy||485||27.75||13,461|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Chawla Lakhmir S (Chief Medical Officer of La Jolla Pharmaceutical Co at the time of this reporting) see the Securities and Exchange Commission (SEC) website.